Cargando…
Diabetic dyslipidaemia
Diabetes mellitus (DM) is an escalating pandemic and an established cardiovascular risk factor. An important aspect of the interaction between DM and atherosclerotic cardiovascular disease (ASCVD) is diabetic dyslipidaemia, an atherogenic dyslipidaemia encompassing quantitative [hypertriglyceridaemi...
Autores principales: | C. Thambiah, Subashini, Lai, Leslie Charles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326412/ https://www.ncbi.nlm.nih.gov/pubmed/34368411 http://dx.doi.org/10.1016/j.plabm.2021.e00248 |
Ejemplares similares
-
Pathophysiology of diabetic dyslipidaemia: where are we?
por: Vergès, Bruno
Publicado: (2015) -
Treatment of Dyslipidaemia in Children
por: Fiorentino, Riccardo, et al.
Publicado: (2021) -
Nutraceuticals in Paediatric Patients with Dyslipidaemia
por: Banderali, Giuseppe, et al.
Publicado: (2022) -
Dyslipidaemia in Type 1 Diabetes: Molecular Mechanisms and Therapeutic Opportunities
por: O’Brien, Stephen T., et al.
Publicado: (2021) -
Nutraceuticals for the Control of Dyslipidaemias in Clinical Practice
por: Penson, Peter E., et al.
Publicado: (2021)